We are live on ! Find out more
JG

Jefferies Group Portfolio holdings

AUM $12B
1-Year Est. Return 6.2%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
-6.2%
3 Year Est. Return
+88.85%
5 Year Est. Return
+123.14%
10 Year Est. Return
AUM
$12.9B
AUM Growth
+$14.9M
Cap. Flow
-$1.43B
Cap. Flow %
-11.05%
Top 10 Hldgs %
19%
Holding
3,286
New
630
Increased
768
Reduced
929
Closed
776

Sector Composition

Rank Sector Weight
1 Healthcare 4.69%
2 Technology 4.39%
3 Industrials 3.75%
4 Real Estate 2.97%
5 Communication Services 2.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVGW
1226
DELISTED
Calavo Growers
CVGW
$1.38M 0.01%
+15,200
New +$1.36M
EXP icon
1227
Eagle Materials
EXP
$6.6B
$1.38M 0.01%
+15,189
New +$1.39M
EQR icon
1228
CALL
Equity Residential
EQR
$25.4B
$1.38M 0.01%
17,000
-31,400
-65% -$2.67M
CRH icon
1229
CRH
CRH
$66.7B
$1.38M 0.01%
+34,105
New +$1.26M
USMV icon
1230
iShares MSCI USA Min Vol Factor ETF
USMV
$23.2B
$1.38M 0.01%
20,965
MDT icon
1231
Medtronic
MDT
$107B
$1.37M 0.01%
12,109
+11,193
+1,222% +$1.23M
JKHY icon
1232
Jack Henry & Associates
JKHY
$10.7B
$1.37M 0.01%
+9,428
New +$1.38M
TRUE
1233
DELISTED
TrueCar
TRUE
$1.37M 0.01%
288,987
+17,041
+6% +$71.1K
MCK icon
1234
CALL
McKesson
MCK
$98.5B
$1.37M 0.01%
9,900
+2,600
+36% +$367K
BSX icon
1235
CALL
Boston Scientific
BSX
$65.8B
$1.37M 0.01%
30,200
-49,600
-62% -$2.08M
AXTA icon
1236
CALL
Axalta
AXTA
$7.01B
$1.36M 0.01%
44,900
-275,100
-86% -$8.11M
ALNY icon
1237
Alnylam Pharmaceuticals
ALNY
$36.3B
$1.36M 0.01%
11,820
+8,607
+268% +$858K
STE icon
1238
Steris
STE
$20.9B
$1.36M 0.01%
8,926
-21,241
-70% -$3.11M
Z icon
1239
CALL
Zillow
Z
$7.04B
$1.36M 0.01%
29,600
-19,800
-40% -$738K
CCI.PRA
1240
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
$1.36M 0.01%
1,058
-11
-1% -$13.5K
LDP icon
1241
Cohen & Steers Duration Preferred & Income Fund
LDP
$599M
$1.35M 0.01%
51,573
-550
-1% -$14.3K
BIO icon
1242
Bio-Rad Laboratories Class A
BIO
$8.42B
$1.34M 0.01%
3,630
-6,670
-65% -$2.35M
TRU icon
1243
TransUnion
TRU
$14.8B
$1.34M 0.01%
15,666
-7,484
-32% -$623K
RTN
1244
PUT
DELISTED
Raytheon Company
RTN
$1.34M 0.01%
6,100
-33,700
-85% -$7.12M
LAMR icon
1245
Lamar Advertising Co
LAMR
$16.2B
$1.34M 0.01%
+15,000
New +$1.26M
UTHR icon
1246
United Therapeutics
UTHR
$26.3B
$1.34M 0.01%
+15,191
New +$1.34M
ALGN icon
1247
Align Technology
ALGN
$12B
$1.34M 0.01%
4,791
-1,140
-19% -$284K
TSN icon
1248
Tyson Foods
TSN
$20.2B
$1.34M 0.01%
14,673
-11,109
-43% -$955K
VALE icon
1249
CALL
Vale
VALE
$62.9B
$1.34M 0.01%
101,200
-255,000
-72% -$3.06M
CWT icon
1250
California Water Service
CWT
$3.04B
$1.33M 0.01%
+25,898
New +$1.35M

Similar funds

Jefferies Group's Q4 2019 Portfolio in Review

As of Q4 2019, Jefferies Group held 3,286 positions worth $12.9B, up 0.12% from $12.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Jefferies Group withdrew a net $1.43B in Q4 2019, closing 776 positions and reducing 929 holdings. Its most notable exit was Celgene Corp, an estimated $57.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 4.7% of assets, up from 3.8% a quarter earlier, followed by Technology and Industrials.

Against the trend, Jefferies Group opened a new position in CyrusOne Inc Common Stock worth $106M.

  • Jefferies Group's largest Q4 2019 buy was CyrusOne Inc Common Stock: 1,619,990 shares worth $106M.
  • Jefferies Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $428M increase.
  • Jefferies Group's biggest Q4 2019 reduction was NXP Semiconductors, cutting an estimated $80.8M.
  • Jefferies Group fully exited Celgene Corp in Q4 2019, selling an estimated $57.4M.
  • Jefferies Group's ten largest holdings make up 19% of its $12.9B portfolio in Q4 2019.
  • Jefferies Group opened 630 new positions and closed 776 in Q4 2019.
  • Jefferies Group's portfolio value rose 0.12% quarter-over-quarter to $12.9B.

Based on Jefferies Group's 13F filing for Q4 2019, filed 13 Feb 2020.